Hydrophobic tails enable diverse functions of the extracellular chaperone clusterin
Patricia Yuste‐ChecaiD, Alonso I. Carvajal, Chenchen MiiD, Sarah PaatziD, F. Ulrich HartliD, Andreas BracheriD
Abstract
Clusterin, a conserved secretory glycoprotein abundant in blood plasma and cerebrospinal fluid, functions as a molecular chaperone and apolipoprotein (Wyatt et al. 2013, Raulin et al. 2022). Dysregulation of clusterin is linked to late-onset Alzheimers disease, cardiovascular pathology and cancer (Rohne et al. 2016, Satapathy and Wilson 2021, Wilson et al. 2023). Despite its prominent role in extracellular proteostasis, the chaperone mechanism of clusterin has remained unclear. Here we present crystal structures of human clusterin, revealing a discontinuous three-domain architecture. Structure-based mutational analysis demonstrated that two intrinsically disordered, hydrophobic peptide tails enable diverse clusterin activities. Resembling the N-terminal substrate binding regions of so-called small heat shock proteins, these sequences mediate clusterins chaperone function in suppressing amyloid-{beta}, tau and -synuclein aggregation. In conjunction with highly conserved surface areas, the tail segments also participate in clusterin binding to very low density lipoprotein receptor (VLDLR) and cellular uptake. Moreover, the disordered tails cooperate with an adjacent amphipathic helix in lipoprotein formation, but remain accessible for chaperone function in the lipoprotein complex. The remarkable versatility of these sequences allows clusterin to function alone or bound to lipid in maintaining solubility of aberrant extracellular proteins and facilitating their clearance by endocytosis and lysosomal degradation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 18
- FWCI
- 7.41
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Two sites in the C-terminal β-chain tail mediate interactions of the chaperone clusterin with amyloid beta and other misfolded client proteins
Sandeep Satapathy, Ye Shen, … Mark R. Wilson·bioRxiv·Mar 16, 2025
- Clusterin in Alzheimer's disease: an amyloidogenic inhibitor of amyloid formation
P. M. Spatharas, G. I. Nasi, … V. A. Iconomidou·bioRxiv·Apr 2, 2021
- The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
P. Yuste-Checa, V. A. Trinkaus, … F. U. Hartl·bioRxiv·Jul 16, 2021
- Mutations in the juxtamembrane segment of the cholesterol-binding site of APP alter its processing and promotes production of shorter, less toxic Aβ peptides.
Linda Hanbouch, Béatrice Schaack, … Marie‐Claude Potier·bioRxiv·Nov 16, 2020
- Extracellular chaperones modulate AL light chains fibrillar aggregation and contribute to amyloid structural heterogeneity
Loredana Marchese, Mariagrazia Battaglia, … Francesca Lavatelli·bioRxiv·Jun 2, 2026
- Oligomer-to-Monomer Transition Underlies the Chaperone Function of AAGAB in AP1/AP2 Assembly